Enveric Biosciences (ENVB) affiliates report 158,732 warrants; Easton 161,232

Rhea-AI Filing Summary

Enveric Biosciences: Schedule 13G/A showing significant warrant holdings by Lind affiliates and Jeff Easton. The filing reports 158,732 warrants held by Lind Global Fund III LP / Lind Global Partners III LLC (representing 7.76% of the class) and 161,232 warrants attributable to Jeff Easton (representing 7.87%). The ownership notes each include 79,366 Series G Warrants and 79,366 Series H Warrants; Jeff Easton is further associated with 2,500 warrants held by Lind Global Fund II. The warrants contain a conversion limitation that prevents conversion if doing so would cause beneficial ownership to exceed 9.99%.

Insights

Securities Ownership Analyst

Institutional holders report warrant positions near single‑digit ownership caps.

The filing lists 158,732 warrants for Lind Global Fund III LP / Lind Global Partners III LLC and 161,232 warrants attributable to Jeff Easton, with percentages of 7.76% and 7.87%, respectively. These counts are reported as beneficial ownership and include two warrant series (Series G and Series H).

Each warrant instrument includes a provision limiting conversion above 9.99% beneficial ownership; timing and exercise decisions rest with the holders and the conversion cap is a binding contractual constraint disclosed in the filing.

Corporate Governance Specialist

Control and attribution clarified via general partner and managing member relationships.

The statement attributes sole voting and dispositive power to Lind Global Partners III LLC over Lind Global Fund III LP holdings and to Jeff Easton as managing member. Signatures show the reporting structure for regulatory attribution.

These facts describe ownership and control; cash‑flow treatment or planned exercises are not stated in the excerpt and thus not addressed here.

Key Figures

Lind Global Fund III holdings: 158,732 warrants Lind Global Fund III percent: 7.76% Jeff Easton holdings: 161,232 warrants +5 more

8 metrics

Lind Global Fund III holdings 158,732 warrants cover page / amount beneficially owned

Lind Global Fund III percent 7.76% cover page / percent of class

Jeff Easton holdings 161,232 warrants cover page / amount beneficially owned

Jeff Easton percent 7.87% cover page / percent of class

Series G Warrants (per reporting person) 79,366 warrants cover page comment describing composition

Series H Warrants (per reporting person) 79,366 warrants cover page comment describing composition

Additional warrants associated with Easton 2,500 warrants held by Lind Global Fund II as stated in Easton comment

Conversion beneficial ownership cap 9.99% warrant provision limiting conversion beyond this threshold

Key Terms

Series G Warrants / Series H Warrants, Sole Dispositive Power, Beneficially own, Schedule 13G/A

4 terms

Series G Warrants / Series H Warrants financial

"Comment: "79,366 warrants to purchase shares of common stock (the \"Series G Warrants\")""

Sole Dispositive Power regulatory

"Row entry: "Sole Dispositive Power 158,732.00""

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Beneficially own regulatory

"Comment: "would cause the holder to beneficially own greater than 9.99%""

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

Schedule 13G/A regulatory

"Filing header: "SCHEDULE 13G/A""

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Enveric Biosciences, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

29405E505

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29405E505

1

Names of Reporting Persons

Lind Global Fund III LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 150.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 158,732.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

158,732.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.76 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of (i) 79,366 warrants to purchase shares of common stock (the "Series G Warrants") and (ii) 79,366 warrants to purchase shares of common stock (the "Series H Warrants, together with the Series G Warrants, the "Warrants"). (2) The Warrants include a provision limiting the holder's ability to convert the Warrants if such conversion would cause the holder to beneficially own greater than 9.99% of the Company.

SCHEDULE 13G

CUSIP Number(s): 29405E505

1

Names of Reporting Persons

Lind Global Partners III LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 158,732.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 158,732.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

158,732.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.76 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of (i) 79,366 Series G Warrants and (ii) 79,366 Series H Warrants. (2) The Warrants include a provision limiting the holder's ability to convert the Warrants if such conversion would cause the holder to beneficially own greater than 9.99% of the Company.

SCHEDULE 13G

CUSIP Number(s): 29405E505

1

Names of Reporting Persons

EASTON JEFF

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 161,232.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 161,232.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

161,232.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.87 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) The reporting person's ownership consists of (i) 79,366 Series G Warrants and (ii) 79,366 Series H Warrants, in each case held by Lind Global Fund III to purchase shares of common stock, and (iii) 2,500 warrants held by Lind Global Fund II to purchase shares of common stock. (2) The Warrants include a provision limiting the holder's ability to convert the Warrants if such conversion would cause the holder to beneficially own greater than 9.99% of the Company.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Enveric Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 245 First Street, Riverview II, 18th Floor, Cambridge, Massachusetts, 02142
Item 2.
(a)	Name of person filing: This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): o Lind Global Fund III LP, a Delaware limited partnership; o Lind Global Partners III LLC, a Delaware limited liability company; and o Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners III LLC, the general partner of Lind Global Fund III LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP. Jeff Easton, the managing member of Lind Global Partners III LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP.
(b)	Address or principal business office or, if none, residence: The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022
(c)	Citizenship: See Row 4 of cover page for each Reporting Person.
(d)	Title of class of securities: Common Stock, $0.01 par value
(e)	CUSIP No.: 29405E505
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of cover page for each Reporting Person.
(b)	Percent of class: See Row 11 of cover page for each Reporting Person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of cover page for each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lind Global Fund III LP

Signature:	By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton
Name/Title:	Jeff Easton, Managing Member
Date:	05/15/2026

Lind Global Partners III LLC

Signature:	/s/ Jeff Easton
Name/Title:	Jeff Easton, Managing Member
Date:	05/15/2026

EASTON JEFF

Signature:	/s/ Jeff Easton
Name/Title:	Jeff Easton
Date:	05/15/2026

FAQ

What stake does Lind Global Fund III hold in ENVB?

Lind Global Fund III is reported to beneficially hold 158,732 warrants, representing 7.76% of the class as stated on the cover page. The filing attributes sole voting and dispositive power to Lind Global Partners III LLC.

How many warrants does Jeff Easton have attributed to him in the filing?

Jeff Easton is shown with 161,232 warrants attributable to him, equal to 7.87% of the class on the cover page. This total includes warrants held by affiliated Lind entities, including 2,500 warrants held by Lind Global Fund II.

What types of warrants are disclosed in the Schedule 13G/A for ENVB?

The filing discloses two warrant series: Series G Warrants and Series H Warrants, each with 79,366 warrants held by the named reporting persons, totaling the reported positions in the cover rows.

Is there any conversion limit noted for the warrants?

Yes. The warrants include a provision limiting conversion if conversion would cause the holder to beneficially own greater than 9.99% of the company, as stated verbatim in the comments on the cover pages.

Who is listed as having voting and dispositive power over the holdings?

The filing states that Lind Global Partners III LLC may be deemed to have sole voting and dispositive power over Lind Global Fund III LP’s holdings, and Jeff Easton is the managing member of Lind Global Partners III LLC.